226 related articles for article (PubMed ID: 23349739)
1. Characterization of a stable, metronidazole-resistant Clostridium difficile clinical isolate.
Lynch T; Chong P; Zhang J; Hizon R; Du T; Graham MR; Beniac DR; Booth TF; Kibsey P; Miller M; Gravel D; Mulvey MR;
PLoS One; 2013; 8(1):e53757. PubMed ID: 23349739
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis of a NAP1 Clostridium difficile clinical isolate resistant to metronidazole.
Chong PM; Lynch T; McCorrister S; Kibsey P; Miller M; Gravel D; Westmacott GR; Mulvey MR;
PLoS One; 2014; 9(1):e82622. PubMed ID: 24400070
[TBL] [Abstract][Full Text] [Related]
3. Plasmid-mediated metronidazole resistance in Clostridioides difficile.
Boekhoud IM; Hornung BVH; Sevilla E; Harmanus C; Bos-Sanders IMJG; Terveer EM; Bolea R; Corver J; Kuijper EJ; Smits WK
Nat Commun; 2020 Jan; 11(1):598. PubMed ID: 32001686
[TBL] [Abstract][Full Text] [Related]
4. A Clostridium difficile Lineage Endemic to Costa Rican Hospitals Is Multidrug Resistant by Acquisition of Chromosomal Mutations and Novel Mobile Genetic Elements.
Ramírez-Vargas G; Quesada-Gómez C; Acuña-Amador L; López-Ureña D; Murillo T; Del Mar Gamboa-Coronado M; Chaves-Olarte E; Thomson N; Rodríguez-Cavallini E; Rodríguez C
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137804
[TBL] [Abstract][Full Text] [Related]
5. Metronidazole-resistant Clostridioides difficile: genomic and transcriptomic traits acquired under in-vitro metronidazole induction.
Xu T; Zhou F; Wang L; Wu S; Huang H
Int J Antimicrob Agents; 2022 May; 59(5):106570. PubMed ID: 35296432
[TBL] [Abstract][Full Text] [Related]
6. The tcdA-negative and tcdB-positive Clostridium difficile ST81 clone exhibits a high level of resistance to fluoroquinolones: a multi-centre study in Beijing, China.
Cheng JW; Liu C; Kudinha T; Xiao M; Fan X; Yang CX; Wei M; Liang GW; Shao DH; Xiong ZJ; Hou X; Yu SY; Wang Y; Yang QW; Su JR; Xu YC
Int J Antimicrob Agents; 2020 Jul; 56(1):105981. PubMed ID: 32330584
[TBL] [Abstract][Full Text] [Related]
7. Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin.
Peláez T; Alcalá L; Alonso R; Rodríguez-Créixems M; García-Lechuz JM; Bouza E
Antimicrob Agents Chemother; 2002 Jun; 46(6):1647-50. PubMed ID: 12019070
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial resistance in Clostridioides difficile.
O'Grady K; Knight DR; Riley TV
Eur J Clin Microbiol Infect Dis; 2021 Dec; 40(12):2459-2478. PubMed ID: 34427801
[TBL] [Abstract][Full Text] [Related]
9. Sequence-Based Identification of Metronidazole-Resistant Clostridioides difficile Isolates.
Smits WK; Harmanus C; Sanders IMJG; Bry L; Blackwell GA; Ducarmon QR; de Oliveira Ferreira E; Kuijper EJ
Emerg Infect Dis; 2022 Nov; 28(11):2308-2311. PubMed ID: 36286226
[TBL] [Abstract][Full Text] [Related]
10. Multidisciplinary analysis of a nontoxigenic Clostridium difficile strain with stable resistance to metronidazole.
Moura I; Monot M; Tani C; Spigaglia P; Barbanti F; Norais N; Dupuy B; Bouza E; Mastrantonio P
Antimicrob Agents Chemother; 2014 Aug; 58(8):4957-60. PubMed ID: 24913157
[TBL] [Abstract][Full Text] [Related]
11. Impact of subinhibitory concentrations of metronidazole on proteome of Clostridioides difficile strains with different levels of susceptibility.
Doan TH; Yen-Nicolaÿ S; Bernet-Camard MF; Martin-Verstraete I; Péchiné S
PLoS One; 2020; 15(11):e0241903. PubMed ID: 33166349
[TBL] [Abstract][Full Text] [Related]
12. Fidaxomicin inhibits spore production in Clostridium difficile.
Babakhani F; Bouillaut L; Gomez A; Sears P; Nguyen L; Sonenshein AL
Clin Infect Dis; 2012 Aug; 55 Suppl 2(Suppl 2):S162-9. PubMed ID: 22752866
[TBL] [Abstract][Full Text] [Related]
13. Metronidazole resistance in Clostridium difficile is heterogeneous.
Peláez T; Cercenado E; Alcalá L; Marín M; Martín-López A; Martínez-Alarcón J; Catalán P; Sánchez-Somolinos M; Bouza E
J Clin Microbiol; 2008 Sep; 46(9):3028-32. PubMed ID: 18650353
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility pattern of Clostridium difficile and its relation to PCR ribotypes in a Swedish university hospital.
Aspevall O; Lundberg A; Burman LG; Akerlund T; Svenungsson B
Antimicrob Agents Chemother; 2006 May; 50(5):1890-2. PubMed ID: 16641471
[TBL] [Abstract][Full Text] [Related]
15. The Integrity of Heme Is Essential for Reproducible Detection of Metronidazole-Resistant Clostridioides difficile by Agar Dilution Susceptibility Tests.
Wu X; Shen WJ; Deshpande A; Olaitan AO; Palmer KL; Garey KW; Hurdle JG
J Clin Microbiol; 2021 Aug; 59(9):e0058521. PubMed ID: 34132582
[TBL] [Abstract][Full Text] [Related]
16. In vivo selection of rifamycin-resistant Clostridium difficile during rifaximin therapy.
Carman RJ; Boone JH; Grover H; Wickham KN; Chen L
Antimicrob Agents Chemother; 2012 Nov; 56(11):6019-20. PubMed ID: 22908175
[TBL] [Abstract][Full Text] [Related]
17. Coinfection and Emergence of Rifamycin Resistance during a Recurrent Clostridium difficile Infection.
Stevenson EC; Major GA; Spiller RC; Kuehne SA; Minton NP
J Clin Microbiol; 2016 Nov; 54(11):2689-2694. PubMed ID: 27558181
[TBL] [Abstract][Full Text] [Related]
18. The molecular characters and antibiotic resistance of Clostridioides difficile from economic animals in China.
Zhang WZ; Li WG; Liu YQ; Gu WP; Zhang Q; Li H; Liu ZJ; Zhang X; Wu Y; Lu JX
BMC Microbiol; 2020 Mar; 20(1):70. PubMed ID: 32228454
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial resistance in Clostridioides (Clostridium) difficile derived from humans: a systematic review and meta-analysis.
Sholeh M; Krutova M; Forouzesh M; Mironov S; Sadeghifard N; Molaeipour L; Maleki A; Kouhsari E
Antimicrob Resist Infect Control; 2020 Sep; 9(1):158. PubMed ID: 32977835
[TBL] [Abstract][Full Text] [Related]
20. Repurposing a platelet aggregation inhibitor ticagrelor as an antimicrobial against Clostridioides difficile.
Phanchana M; Phetruen T; Harnvoravongchai P; Raksat P; Ounjai P; Chankhamhaengdecha S; Janvilisri T
Sci Rep; 2020 Apr; 10(1):6497. PubMed ID: 32300130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
